Why International Patients Prefer India for Leukemia Treatment
Discover why international patients choose India for leukemia treatment—advanced therapies, expert hematologists, affordable care, and world-class cancer hospitals.
Leukemia is a blood cancer which targets the lymphatic system and the bone marrow. One of the reasons why India is a common choice of people seeking treatment of leukemia is that India has a well-developed medical infrastructure, specialist oncologists and the prices of treatment there are by far cheaper than those in the Western world.
The Leukemia treated in India are:
ALL or Acute Lymphoblastic Leukemia
ALL is primarily observed in children, but it can also affect adults, in which case, the symptoms may include fatigue, infection, easy bleeding and bruising, fever, swollen lymph nodes. The main available forms of therapy are chemotherapy, target therapy and bone marrow transplant.
Acute Myeloid Leukemia (AML)
Acute Myeloid Leukemia (AML) is categorized in adult and childhood leukemia that rapidly progresses and has some of the symptoms like anemia, easy bruising, recurrent infections and bone pain. They comprise chemotherapy, mammary therapy, and transplantation of bone marrow.
Chronic Lymphocytic Leukemia (CLL)
CLL is mostly prevalent in the older people and is characterized by the gradual development of leukemia in the lymphocytes. Therefore, some of the symptoms are; exhaustion, enlargement of the lymph nodes, and recurrent infections. The treatment plan might not call for a quick response, reaction, effort or measure.
Chronic Myeloid Leukemia (CML)
CML was recognized mostly in adults, it is slow progressing disease, but sometimes it has a tendency to blast crisis, where it affects myeloid cells. Some of the indicators include; weakness, thinning, sleepless sweating and distended liver. Some treatments that are recommended include the targeted therapy, chemotherapy and bone marrow transplant.
Typical Therapy Choices:
Chemotherapy -The first line therapy is particularly in acute leukemias.
Targeted Therapy - Applicable to certain genetic abnormalities (e.g. Imatinib in CML).
Radiation Therapy - Occasionally this form of treatment is applied alongside others.
Bone Marrow or Stem Cell Transplant- This will work on a high-risk case or relapse.
Immunotherapy- Monoclonal antibodies and CAR-T cell therapy (check select centers in India).
Supportive Care - It consists of antibiotic therapy, blood transfusion and nutritional support.
Factors Affecting Cost of leukemia treatment in India
The overall expense of leukemia treatment in India may greatly differ based on a number of medical, hospital-related, and logistical considerations. Below is an outline of the major factors contributing to the overall cost of treatment:
Type and Stage of Leukemia
Treatment Modality Required
Type of Bone Marrow Transplant (if needed)
Hospital Type and Location
Diagnostic Tests and Monitoring
Length of Hospital Stay and ICU Requirement
Doctor’s Expertise and Consultation Fees
Post-Treatment Care and Follow-Up
Donor Search & Registry Charges (for transplant)
International Patient Services
Advanced leukemia therapies in India
In India, there is a greater availability of treatment of leukemia, and some of the leading hospitals in India have state of the art treatments that are at par with the world. The following are the most promising forms of treatment that leukemia has to offer at present in the country of India especially in major hospitals, and cancer centres.
Targeted Therapy
Targeted drugs strike precisely cancer cells with the minimal damage to other healthy ones.
Ivosidenib, Enasidenib IB, IL, ID, IF, IP, IJ, IK, IL, IM, IN, IO, IP, IQ, IR IOS, vibrant, idzable
Venetoclax + Azacitidine - in older /unfit patients of AML.
Immunotherapy
Immunotherapy enhances or alters the immune environment in order to attack leukemia cells.
Types:
Monoclonal Antibodies
Rituximab in CD 20 + CLL
Blinatumomab- in B-cell ALL
Inotuzumab Ozogamicin in relapsed /refractory ALL
Checkpoint Inhibitors
Cases of clinical trials or special resistant cases (e.g. Pembrolizumab)
CAR-T Cells Therapy (Trending in India)
One of the options currently in the most advanced and promising stages, in particular, in relapsed/refractory B-ALL and DLBCL, is CAR-T (Chimeric Antigen Receptor T-cell therapy).
Bone Marrow / Stem cell Transplantation
India is able to carry advanced methods of transplant:
Haploidentical Transplants (using family donors who are half-matched)
Matched Unrelated Donor (MUD) through Indian and international registries (e.g. DATRI)
Cord Blood Transplants in patients with paediatrics
In AML, ALL and relapsed leukemias Applied
Minimal Residual Disease (MRD) Monitoring
The monitoring of MRD has become advanced with advanced labs monitoring their progress by way of Flow cytometry and PCR in order to make treatment decisions and monitor the detection of relapse.
A used particularly in ALL, AML post-chemotherapy
Next-Generation Sequencing, or NGS
Personalized use of therapy plans asking about genetic profiling of leukemia cells (precision medicine).
Helps identify:
Idh1 2, Flt, Npm1 mutations in AML
TP53 or IGHV in CLL
Clinical trials
In India, there are an increasing number of trials concerning leukemia (Phase I-III) and there are:
Induction Therapy: The first goal of the treatment was to place the leukemia into a state of relapse. It uses very strong chemotherapy medications, mostly administered through an IV drip.
Common drugs: Ara C, Daumorubicin, Idarubicin.
Consolidation Therapy: This is done after remission in order to kill of any leukemia cells that may still be present but are too small to be seen.
High-dose Chemotherapy: Occasionally given in individuals where there are chances that the client may relapse.
Bone marrow transplant for leukemia India
Allogeneic Stem Cell Transplant: This is recommended for patients who are most likely to have a relapse. Those include but are not limited to; Auto-transplantation, in which the individual receives his/her own stem cells, deceased donors, in which stem cells are harvested from a deceased person, matched unrelated donor in which stem cells are taken from a stranger with close HLA match to the patient or family member in which stem cells are taken from a related but non-identical donor.
Autologous Stem Cell Transplant: This is where the patient’s own stem cells are collected, stored and then modified by other processes to exterminate any existing malignant cells.
Book leukemia treatment in India with GetWellGo
GetWellGo is regarded as a leading supplier of healthcare services. We help our foreign clients choose the best treatment locations that suit their needs both financially and medically.
We offer:
Complete transparency
Fair costs.
24 hour availability.
Medical E-visas
Online consultation from recognized Indian experts.
Discover the best uterus cancer hospitals in India offering advanced care, expert gynecologic oncologists, and affordable treatment tailored for international patients’ needs.
Travel to India for a Colectomy with GetWellGo. World-class hospitals, expert surgeons, affordable prices, and personalized care for international patients.
GetWellGo is the top choice for international patients seeking cancer treatment in India. Affordable care, expert oncologists, and world-class hospitals.
GetWellGo connects international patients with India’s top hospitals & doctors for Neuroblastoma treatment. Trusted care, expert guidance, better outcomes.
GetWellGo supports international patients with neck cancer care. Explore diagnosis and treatment approaches designed for comfort, clarity, and trusted outcomes.
Advanced treatment options for endometrial cancer at GetWellGo. Expert care and global support tailored for international patients seeking trusted solutions.
India offers expert testicular cancer care for international patients, combining advanced treatments, skilled oncologists, and supportive services for better outcomes and recovery.
Eye cancer treatment in India combines advanced technology, expert oncologists, and cost-effective care. Here’s what international patients need to know before treatment.